Skip to main content
. 2009 Jan;19(1):48–56. doi: 10.1055/s-0028-1103127

Table 2.

Case Material (Preoperative and Postoperative Features)

Case Age/Sex Histology Preop Nerve Losses (VII [I–VI HB]; IX,X,XI,XII) Preop Hearing PTA, (% discr.) Extent of Lesion Procedure and Date (mm/yy) Postop Nerve Changes (VII; IX,X,XI,XII) Postop Hearing (Change; Follow-up)
/ = Preoperative normal or postoperative unchanged.
Preop, before surgery; HB, House-Brackmann grade; PTA, pure tone average; discr., discrimination; postop, after surgery; JF, jugular fossa; CPA, cerebellopontine angle; POTS, petro-occipital trans-sigmoid approach; i, intradural; e, extradural; NED, no evidence of disease; n, nerve; C, clivus; P, petrous bone; Co, occipital condyle; A, petrous apex; CC, carotid canal; TL, translabyrinthine; PPS, parapharyngeal space; T, tympanum; M, mastoid; 7th graft, graft on the facial nerve; Tpl, tympanoplasty; IAC, internal auditory canal; Tp, transpetrous; DOD, dead of disease; AWD, alive with disease; G1, grade of differentiation.
1 40/F Schwannoma / / 29.0% JF, CPA POTS, i + e 09/85 / IX,X / NED 15 y
2 16/F Schwannoma 12th n. / XII 0, 100% C, Co, JF POTS, e 09/86 / IX,X,XI / NED 18 y
3 48/F Schwannoma / IX,X,XII deaf JF, A, CC, CPA, Co POTS + TL, i + e 07/87 / / / NED 10 y
4 49/M Schwannoma / XII 20, 100% JF, CC, PPS POTS, e 10/89 / / / NED 10 y
5 25/M Schwannoma II / deaf JF, A, CC, T, CPA POTS, i + e 06/90 / / / NED 10 y
6 48/F Schwannoma / /IX,X,XI,XII 20, 100% JF, PPS POTS, e 09/90 / / / NED 10 y
7 37/M Schwannoma / // deaf JF, CPA POTS + TL, i + e 09/90 / / / NED 10 y
8 39/M Schwannoma / /IX,X,XI 40, 70% JF, CPA, PPS POTS, i + e 01/91 / / / NED 10 y
9 23/M Schwannoma / /IX,X,XI,XII 10, 100% JF, CC, CPA, Co POTS, i + e 09/92 / / / NED 10 y
10 40/F Schwannoma / /IX,X,XI 15, 100% JF, CPA, PPS POTS, i + e 08/93 II / / NED 10 y
11 42/F Schwannoma / X,XII / JF, PPS, CC POTS, e 11/96 / / / NED 5 y
12 58/M Schwannoma / / deaf JF, CPA,PPS POTS + TL, i + e 02/96 / IX,X / NED 5 y
13 45/F Schwannoma / /IX,X,XI,XII / JF, CC POTS, e 01/99 / / / NED 5 y
14 50/M Schwannoma / / deaf JF, CPA, PPS POTS, i + e 12/99 / IX,X / NED 5 y
15 26/M Schwannoma 7th n. V / / M, JF, P POTS, e 06/96 III / / NED 5 y
16 51/M Schwannoma / IX,X 55, 60% JF, M, 7N. POTS, e 09/00 III / / NED 5 y
17 22/M Schwannoma / IX,X JF, Co, CPA POTS, i + e 10/00 / / / NED 5 y
18 41/M Schwannoma / IX,X JF, Co POTS, e 05/04 NED 1 y
19 40/M Schwannoma 8th n. III / deaf JF, A POTS, i + e 05/95 / / / NED 9 y
20 45/M Schwannoma 7th n. II / 50, 100% JF, T, PPS POTS, e + 7th graft 06/92 III / / 20, 100%
21 68/F Paragangl. C1 D1 / IX,X,XI,XII 35, 90% JF, CPA, C POTS, i + e 11/89 / / / NED 10 y
22 39/F Paragangl. C1 D1 / IX,X,XII 15, 100% JF, CPA, Co POTS, i + e 11/89 / XI / NED 10 y
23 65/F Paragangl. C1 VI IX,X,XI,XII 15, 100% JF POTS, e + 7th graft 07/90 IV / / NED 10 y
24 69/F Paragangl. C1 / / 45, 80% JF POTS, e, deliberate partial removal 11/91 / / / AWD,DOD C 7 y
25 51/M Paragangl. C1 D1 III IX,X deaf JF, A, Co, CPA POTS + TL, i + e 05/92 / / / NED 10 y
26 66/F Paragangl. C1( + mening.) / / 50, 50% JF, CPA POTS, i + e 04/99 / / / NED 5 y
27 44/F Meningioma / / 24, 90% JF, CPA POTS, i + e 07/90 / IX,X,XI / NED 15 y
28 42/F Meningioma / / deaf JF, CPA, IAC POTS, i + e 06/91 / XI,X / NED 8 y
29 60/M Meningioma / / 55, 80% JF, CPA POTS, i + e 09/91 / IX,X,XI 60, 50% LOST
30 42/F Meningioma / / 20, 100% JF, Co, CPA, CC POTS, i + e 12/93 / IX,X deaf NED 10 y
31 35/F Meningioma / / 10, 100% JF, T, A, CC, Co, CPA, PPS POTS, i + e 06/94 / IX,X,XI,XII deaf NED 10 y
32 44/F Meningioma / / 60, 40% JF, CPA POTS, i + e 03/98 / IX,X,XI deaf NED 5 y
33 39/F Meningioma / / 10, 100% JF, CPA, SS, PPS POTS, i + e 06/02 / IX,X,XI,XII deaf NED 3 y
34 30/M Cholesteatoma / / deaf JF, A POTS, e 01/85 / / / NED 10 y
35 76/M Cholesteatoma VI / 55, 70% JF, l, T, CPA POTS, e 02/93 / / deaf NED 10 y
36 46/F Cholesteatoma / / 10, 100% JF, T, CC POTS + petrosectomy, e 06/94 / / 45, 50% NED 10 y
37 61/M Cholesteatoma / / 45, 50% JF, M POTS, e 12/00 / / deaf NED 3 y
38 40/F Cholesteatoma III / deaf JF, M POTS + TL, e 08/85 / / / NED 10 y
39 28/M Cholesteatema / / deaf JF, M, T POTS + Tpl, e 04/98 / / / NED 5 y
40 22/M Cholest. Granuloma VI / deaf JF, CPA, A, CC, IAC POTS, Tp + Graft, i + e 07/90 III / / NED 10 y
41 40/F Chordoma / IX,X,XII 27, 100% JF, CC, Co, T, PPS POTS, e 12/90 / / / DOD 5 y
42 16/F Chordoma / IX,X,XI,XII / JF, PPS POTS, e 06/98 / / / AWD 8 y
43 56/M Chordoma / IX,X,XI,XII / JF POTS, e 01/96 / / / DOD 8 y
44 47/F Chordoma / IX,XII / JF, Cl, Co, A POTS, e 12/02 / / deaf AWD 3 y
45 22/F Chondrosar. G1 / / 19, 100% JF, A, CC POTS, e 11/97 / / / NED 7 y
46 23/F Chondrosarc. G1 / / 10, 100% JF, A, Cl, CC POTS, e 05/98 / / / NED 6 y
47 60/M Chondrosarc. G1 / IX,X,XI,XII 50, 40% JF, PPS POTS, e 02/98 / / deaf DOD 4 y
48 54/F Chondrosarc. G1 VIth n. / / 15, 100% JF, A,Cl, Co POTS, e 12/00 / IX,X deaf NED 3 y
49 36/M Chondrosarc. G1 / / 30, 90% JF, Co, CC, PPS POTS, e 03/01 / / / NED 3 y
50 37/M Chondrosarc. G1 / IX,X,XI,XII 45, 70% JF, Co, Cl, CC POTS, e 11/01 / / deaf NED 3 y
51 26/M Papillary aden. / IX,X deaf JF, CC POTS + TL, i + e 05/95 / / / NED 7 y
52 56/M Papillary aden. III / deaf JF, CPA, A POTS, i + e 03/97 V / / NED 5 y
53 25/M Papillary aden. / / deaf JF, CPA POTS, i + e 11/99 / / / NED 4 y
54 61/F Epithelioid hemangioma / IX,X,XI,XII 35, 70% JF, Co, C POTS, e 07/96 / / 90, 0% NED 8 y
55 24/M Teratoma / / 60, 90% JF, PPS POTS, e 10/89 / / / NED 15 y
56 32/M Petrous Cyst / / deaf JF, A, CC, PPS POTS, e 01/92 / / / NED 10 y
57 49/M Residual Paraganglioma III XII deaf JF, CPA, Co POTS, i + e 09/87 / / / AWD 15 y
58 39/M Residual Paraganglioma / / 70, 40% JF,CC, T POTS, e 09/88 / IX,X,XII deaf AWD 15 y
59 50/F Residual Paraganglioma / IX,X,XI,XII 10, 90% CC, C POTS, e 04/89 / / 20, 80% NED 15 y
60 56/M Residual Paraganglioma / IX,X,XI,XII / JF POTS, e 01/96 / IX,X,XII / NED 12 y
61 62/F Residual Paraganglioma III / deaf Co POTS + TL, e 04/90 / IX,XI / NED 12 y